Article Versions Notes

Jain K, McCarley SC, Mukhtar G, Ferlin A, Fleming A, Morris-Rosendahl DJ, Shovlin CL. Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction. Journal of Clinical Medicine. 2024; 13(1):250. https://doi.org/10.3390/jcm13010250

Jain, Kinshuk, Sarah C. McCarley, Ghazel Mukhtar, Anna Ferlin, Andrew Fleming, Deborah J. Morris-Rosendahl, and Claire L. Shovlin. 2024. "Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction" Journal of Clinical Medicine 13, no. 1: 250. https://doi.org/10.3390/jcm13010250

Jain, K., McCarley, S. C., Mukhtar, G., Ferlin, A., Fleming, A., Morris-Rosendahl, D. J., & Shovlin, C. L. (2024). Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction. Journal of Clinical Medicine, 13(1), 250. https://doi.org/10.3390/jcm13010250